Beauty Health Co (SKIN)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Andrew Stanleick
Employees:
700
2165 SPRING STREET, LONG BEACH, CA, 90806
800-603-4996

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. Its flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin.

Data derived from most recent annual or quarterly report
Market Cap 1.601 Billion Shares Outstanding132.208 Million Avg 30-day Volume 2.205 Million
P/E Ratio30.4481 Dividend Yield0.0 EPS0
Price to Revenue3.6936 Debt to Equity4.2813 EBITDA76.351 Million
Price to Book Value7.881 Operating Margin-6.636100000000001 Enterprise Value1.517 Billion
Current Ratio10.793 EPS Growth0.937 Quick Ratio8.818
1 Yr BETA 2.0374 52-week High/Low 18.68 / 8.25 Profit Margin12.1309
Operating Cash Flow Growth-275.8683 Altman Z-Score1.8241 Free Cash Flow to Firm -231.028 Million
Earnings Report2023-05-15

Are you looking for this stock instead?

View SEC Filings from SKIN instead.

View recent insider trading info

Beauty Health Co YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding SKIN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SKIN

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2022-06-30 by FEW JULIUS
  • 4: filed on 2022-06-30 by GRUBER DESIREE
  • 4: filed on 2022-06-30 by MILLER BRIAN CHRISTOPHER
  • 4: filed on 2022-06-30 by KERRICK MICHELLE C.
  • 4: filed on 2022-06-30 by BECK MARLA MALCOLM
  • 4: filed on 2022-06-30 by SCHILLINGER DOUG K.
  • 4: filed on 2022-06-30 by CAPELLAS MICHAEL D
  • 4: filed on 2022-06-06 by BECK MARLA MALCOLM
  • 3: filed on 2022-06-06 by BECK MARLA MALCOLM
  • 4: filed on 2022-05-02 by WATSON DANIEL COPELL

    • Events (8k)

    Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    WOO LIYUAN CHIEF FINANCIAL OFFICER

    • Officer
    		 473,557 2023-03-01 1

    WATSON DANIEL COPELL CHIEF REVENUE OFICER

    • Officer
    		 314,599 2023-03-01 2

    STANLEICK ANDREW ROY CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 391,869 2023-03-01 1

    CAPELLAS MICHAEL D

    • Director
    		 15,093 2022-06-28 1

    BECK MARLA MALCOLM

    • Director
    		 10,520 2022-06-28 3

    KERRICK MICHELLE C.

    • Director
    		 15,093 2022-06-28 1

    FEW JULIUS

    • Director
    		 15,093 2022-06-28 1

    GRUBER DESIREE

    • Director
    		 39,286 2022-06-28 1

    SCHILLINGER DOUG K.

    • Director
    		 15,093 2022-06-28 1

    MILLER BRIAN CHRISTOPHER

    • Director
    		 15,093 2022-06-28 1

    SAUNDERS BRENT L

    • Director
    • EXECUTIVE CHAIRMAN
    		 8,554,667 2022-02-04 0

    PAMAMULL INDRA PRESIDENT, APAC

    • Officer
    		 66,716 2022-02-04 0

    BECKER STEPHAN PRESIDENT, EMEA

    • Officer
    		 55,596 2022-02-04 0

    CARNELL CLINTON E. CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 50,000 2021-09-10 0

    LCP EDGE HOLDCO LLC

    LINDEN CAPITAL III LLC

    LINDEN MANAGER III LP

    LINDEN CAPITAL PARTNERS III LP

    LINDEN CAPITAL PARTNERS III-A LP

    DAVIS ANTHONY B.

    MILLER BRIAN CHRISTOPHER

    • 10% Owner
    		 36,568,002 2021-08-25 0

    SAUNDERS BRENT L

    BLS INVESTOR GROUP LLC

    • Director
    • 10% Owner
    • EXECUTIVE CHAIRMAN
    		9,333,333 2020-10-02 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    WOO LIYUAN - Officer CHIEF FINANCIAL OFFICER

    		2023-03-06 20:41:16 -0500 2023-03-01 A 18,746 a 473,557 direct 0.8453 -2.705 0.8453 2 -5.6636 4

    WATSON DANIEL COPELL - Officer CHIEF REVENUE OFICER

    		2023-03-06 20:43:34 -0500 2023-03-01 A 17,560 a 314,599 direct 0.8453 -2.705 0.8453 2 -5.6636 4

    STANLEICK ANDREW ROY - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-06 20:46:12 -0500 2023-03-01 A 58,536 a 391,869 direct 0.8453 -2.705 0.8453 2 -5.6636 4

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    BEAUTY HEALTH CO-THE SKIN 2023-03-24 22:15:03 UTC 4.2497 0.5703 900000
    BEAUTY HEALTH CO-THE SKIN 2023-03-24 21:45:03 UTC 4.2497 0.5703 900000
    BEAUTY HEALTH CO-THE SKIN 2023-03-24 21:15:03 UTC 4.2497 0.5703 900000
    BEAUTY HEALTH CO-THE SKIN 2023-03-24 20:45:03 UTC 4.2497 0.5703 900000
    BEAUTY HEALTH CO-THE SKIN 2023-03-24 20:15:04 UTC 4.2497 0.5703 900000
    BEAUTY HEALTH CO-THE SKIN 2023-03-24 19:45:03 UTC 4.2497 0.5703 900000
    BEAUTY HEALTH CO-THE SKIN 2023-03-24 19:15:04 UTC 4.2497 0.5703 900000
    BEAUTY HEALTH CO-THE SKIN 2023-03-24 18:45:04 UTC 4.2497 0.5703 950000
    BEAUTY HEALTH CO-THE SKIN 2023-03-24 18:15:03 UTC 4.2497 0.5703 900000
    BEAUTY HEALTH CO-THE SKIN 2023-03-24 17:45:03 UTC 4.2497 0.5703 950000
    BEAUTY HEALTH CO-THE SKIN 2023-03-24 17:15:03 UTC 4.2497 0.5703 950000
    BEAUTY HEALTH CO-THE SKIN 2023-03-24 16:45:03 UTC 4.2497 0.5703 950000
    BEAUTY HEALTH CO-THE SKIN 2023-03-24 16:15:03 UTC 4.2497 0.5703 900000
    BEAUTY HEALTH CO-THE SKIN 2023-03-24 15:45:03 UTC 4.2497 0.5703 900000
    BEAUTY HEALTH CO-THE SKIN 2023-03-24 15:15:03 UTC 4.2497 0.5703 900000
    BEAUTY HEALTH CO-THE SKIN 2023-03-24 14:45:03 UTC 3.9997 0.5703 900000
    BEAUTY HEALTH CO-THE SKIN 2023-03-24 14:15:03 UTC 3.9997 0.5703 1000000
    BEAUTY HEALTH CO-THE SKIN 2023-03-24 13:45:03 UTC 3.9997 0.5703 1000000
    BEAUTY HEALTH CO-THE SKIN 2023-03-24 13:15:04 UTC 3.9997 0.5703 1000000
    BEAUTY HEALTH CO-THE SKIN 2023-03-24 12:45:03 UTC 3.9997 0.5703 1000000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund SKIN -10077.0 shares, $-115180.11 2022-10-31 N-PORT
    Morningstar Funds Trust- Morningstar Alternatives Fund SKIN -24510.0 shares, $-280149.3 2022-10-31 N-PORT
    Calamos Investment Trust/IL- Calamos Market Neutral Income Fund SKIN -173100.0 shares, $-1978533.0 2022-10-31 N-PORT
    Columbia Funds Series Trust I- Multi-Manager Directional Alternative Strategies Fund SKIN -1515.0 shares, $-17316.45 2022-10-31 N-PORT
    PACE SELECT ADVISORS TRUST- PACE Alternative Strategies Investments SKIN -1582.0 shares, $-18082.26 2022-10-31 N-PORT
    INVESTMENT MANAGERS SERIES TRUST- 361 Global Long/Short Equity Fund SKIN -32806.0 shares, $-374972.58 2022-10-31 N-PORT
    Trust for Professional Managers- Convergence Long/Short Equity ETF SKIN -3614.0 shares, $-38850.5 2022-11-30 N-PORT
    Franklin Alternative Strategies Funds- Franklin K2 Alternative Strategies Fund SKIN -8268.0 shares, $-88881.0 2022-11-30 N-PORT
    Federated Hermes Adviser Series- Federated Hermes MDT Market Neutral Fund SKIN -6308.0 shares, $-57402.8 2022-12-31 N-PORT
    AMERICAN BEACON FUNDS- American Beacon SSI Alternative Income Fund SKIN -18798.0 shares, $-171061.8 2022-12-31 N-PORT
    Guidestone Funds- Strategic Alternatives Fund SKIN -9411.0 shares, $-85640.1 2022-12-30 N-PORT
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund SKIN -600.0 shares, $-5460.0 2022-12-31 N-PORT
    RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund SKIN -3167.0 shares, $-28819.7 2022-12-31 N-PORT
    JNL Series Trust- JNL Multi-Manager Alternative Fund SKIN -16409.0 shares, $-149321.9 2022-12-31 N-PORT
    VANGUARD MONTGOMERY FUNDS- VANGUARD MARKET NEUTRAL FUND SKIN -60462.0 shares, $-550204.2 2022-12-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments